secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2024-09-13T23:59:59+00:00
Accession:  0001493152-24-036223
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharma receives Nasdaq delisting notice for low equity ($801K vs $2.5M)
-------------------------------------------------------------------------------

- Nasdaq notified Shuttle Pharma on Sept 10, 2024 of non-compliance with minimum stockholders' equity of $2.5M; reported equity $801,434.
- Company has 45 days (until Oct 25, 2024) to submit a plan to regain compliance; Nasdaq may grant up to 180-day extension.
- Non-compliance has no immediate effect on listing; if plan rejected or not met, securities could be delisted with appeal rights.
- Company is evaluating actions to regain compliance but no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315224036223/0001493152-24-036223-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315224036223/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-036223

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer